Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis

[1]  Yuan Cheng,et al.  Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Pan Wang,et al.  Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study , 2022, Hepatology International.

[3]  Jingfeng Liu,et al.  Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma , 2021, Frontiers in Oncology.

[4]  Li Xu,et al.  Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Y. Liu,et al.  Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis , 2021, Frontiers in Oncology.

[6]  H. Koga,et al.  Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion , 2021, Cancers.

[7]  D. Ng,et al.  The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis , 2021, Chemotherapy.

[8]  N. Lyu,et al.  Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization as initial treatment for locally advanced hepatocellular carcinoma: a propensity score-matching analysis. , 2021, Journal of vascular and interventional radiology : JVIR.

[9]  Bixiang Zhang,et al.  Adjuvant treatment strategy after curative resection for hepatocellular carcinoma , 2021, Frontiers of Medicine.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  W. Dong,et al.  Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection , 2020, International journal of biological sciences.

[12]  K. Uchiyama,et al.  Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial , 2020, Annals of Surgical Oncology.

[13]  A. Nanashima,et al.  Increased Survival Benefit of Adjuvant Intra-arterial Infusion Chemotherapy in HCC Patients with Portal Vein Infiltration after Hepatectomy , 2020, World Journal of Surgery.

[14]  Zhongjun Wu,et al.  Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. , 2020, Clinics and research in hepatology and gastroenterology.

[15]  Li Xu,et al.  Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial , 2020, Annals of Surgical Oncology.

[16]  B. Xing,et al.  Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis , 2020, CardioVascular and Interventional Radiology.

[17]  Zhongguo Zhou,et al.  Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. , 2019, JAMA oncology.

[18]  Kang Wang,et al.  Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  N. Merchant,et al.  Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta‐analysis , 2019, Journal of surgical oncology.

[20]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[21]  Li Xu,et al.  Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety , 2018, Cancer communications.

[22]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[23]  Y. Kong,et al.  Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. , 2018, Journal of hepatology.

[24]  Y. Imai,et al.  Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. , 2018, The lancet. Gastroenterology & hepatology.

[25]  M. Imamura,et al.  Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis , 2018, Oncology.

[26]  Zhao-You Tang,et al.  Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study , 2018, Clinical Cancer Research.

[27]  Huei-Lung Liang,et al.  Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. , 2017, International journal of surgery.

[28]  Chengwu Tang,et al.  Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy , 2017, OncoTargets and therapy.

[29]  E. Hatano,et al.  Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein , 2015, Digestive Surgery.

[30]  T. Yan,et al.  Open surgical repair for chronic type B aortic dissection: a systematic review. , 2014, Annals of cardiothoracic surgery.

[31]  I. Endo,et al.  Adjuvant hepatic arterial infusion chemotherapy with 5-Fluorouracil and interferon after curative resection of hepatocellular carcinoma: a preliminary report. , 2013, Anticancer research.

[32]  H. Baba,et al.  Adjuvant Hepatic Arterial Infusion Chemotherapy after Hepatic Resection of Hepatocellular Carcinoma With Macroscopic Vascular Invasion , 2013, World Journal of Surgery.

[33]  H. Eguchi,et al.  Combined IFN-α and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus , 2012, Experimental and therapeutic medicine.

[34]  S. Ahn,et al.  Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma , 2011, Oncology.

[35]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[36]  O. Matsui,et al.  Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma , 1994, Hepatology.

[37]  A. Nakao,et al.  The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. , 1991, Annals of surgery.

[38]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[39]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.